Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive. Reading time 2 minutes To treat acute pain, doctors in the U ...

A group of novel synthetic opioids emerging in illicit drugs in the United States may be more powerful than fentanyl, 1,000 times more potent than morphine, and may even require more doses of the ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

Although the popular opioid, tramadol, may reduce chronic pain, it also significantly increases risk of serious side effects ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...

A new randomized clinical trial finds that simple reminder emails substantially increase clinicians' use of a database that ...

Luzerne County Council must consider a request to spend $131,360 in opioid settlement funds on chiropractic services intended to prevent acute and chronic pain sufferers from turning to addictive ...